R
REGN
StockHealth CareRegeneron Pharmaceuticals, Inc. Common Stock
$781.67
+$10.88 (+1.41%)
Price Chart
No chart data available
About Regeneron Pharmaceuticals, Inc. Common Stock
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
Market cap
$62.74B
Company information
ExchangeNASDAQ
CountryUnited States of America
CEOLeonard S. Schleifer
Employees6,200
Frequently Asked Questions About REGN
The current price of Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock is $781.67 USD. The stock has changed +1.41% in today's trading session.
You can buy REGN stock through Wallbit, available in 80+ countries worldwide. Simply create an account, fund it, and you can start investing in Regeneron Pharmaceuticals, Inc. Common Stock and thousands of other US stocks.
Regeneron Pharmaceuticals, Inc. Common Stock (REGN) has a market capitalization of $62.74B. Market cap is calculated by multiplying the current stock price by the total number of outstanding shares.
Regeneron Pharmaceuticals, Inc. Common Stock (REGN) operates in the Health Care sector. This classification helps investors understand the company's primary business activities and compare it with similar companies.
The current CEO of Regeneron Pharmaceuticals, Inc. Common Stock (REGN) is Leonard S. Schleifer. The CEO is responsible for the company's overall strategic direction and day-to-day operations.
Regeneron Pharmaceuticals, Inc. Common Stock (REGN) has approximately 6,200 employees worldwide.
Regeneron Pharmaceuticals, Inc. Common Stock (REGN) is listed on the NASDAQ. Trading hours are typically Monday through Friday, 9:30 AM to 4:00 PM Eastern Time.